Report: Apple looks at iPhone for monitoring Parkinson’s patients

Apple (NSDQ:AAPL) is reportedly conducting internal research into whether the iPhone and Apple Watch could be used to monitor drug dosage and wellness data for patients suffering from Parkinson’s disease. The company hopes to show the effectiveness of mobile monitoring, sources told Fast Company. 

Patients who suffer from Parkinson’s disease may only visit their doctor in 6 month intervals, which can lead to improper dosing if their condition improves or worsens. Apple’s efforts are led by Stephen Friend, according to the news outlet. Friend is a former member of Sage Bionetworks, a nonprofit that provides tools for biomedical research.

Get the full story at our sister site, Drug Delivery Business News.

The post Report: Apple looks at iPhone for monitoring Parkinson’s patients appeared first on MassDevice.

from MassDevice http://ift.tt/2fAtHHs